Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Immutep granted European patent for IMP321 in cancer (ASX:IMM)

IMMUTEP GRANTED EUROPEAN PATENT FOR EFTILAGIMOD ALPHA IN CANCER. SYDNEY, AUSTRALIA – 22 August 2019 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Compan...read more

Immutep Announce Appendix 4E & 2019 Full Year Statutory Accounts (ASX:IMM)

Appendix 4E Preliminary Final Report For further information please download the attached PDF:

Ingenia Announce Plans to Expand with Acquisition of Eighth Gate Capital Management (ASX:INA)

Ingenia to expand with acquisition of Eighth Gate Capital Management Highlights Conditions precedent met for acquisition of funds and asset management business (Eighth Gate Capital Manageme...read more

Immutep Ceasing to be a substantial holder from AEF (ASX:IMM)

Form 605 - Notice of ceasing to be a substantial holder For further information please download the attached PDF:

InPayTech (Integrated Payment Technologies Ltd) Announce Appointment of new CEO (ASX:IP1)

Integrated Payment Technologies Limited (ASX: IP1) (InPayTech or the Company) announces that it has appointed Mr Dean Martin to the role of Chief Executive Officer (CEO) effective immediately. Mr M...read more

Immutep, Notice of change of interests of substantial holder (ASX:IMM)

Immutep Limited (ASX:IMM). Notice under section 671B of the Corporations Act 2001 (Cth). For further information, please download the attached PDF.

Immutep completes $6 million entitlement offer (ASX:IMM)

Immutep Limited (ASX:IMM;NASDAQ:IMMP) ("Immutep” or “the Company”) is pleased to announce the completion of its fully underwritten pro rata non-renounceable entitlement o...read more

Immutep Announce Operational Update (ASX:IMM)

TACTI-002 patient recruitment update Three patients now enrolled and dosed in INSIGHT-004, recruitment ongoing Significant eftilagimod alpha clinical data expected in coming months:...read more

Immutep release Appendix 4C (ASX:IMM)

Quarterly report for entities subject to Listing Rule 4.7B For further information please download the attached PDF:

Immutep Announce Notice of initial substantial holder (ASX:IMM)

Form 603 For further information please download the attached PDF:

Immutep Announce Change in Substantial Holding (ASX:IMM)

Form 604 - Notice of change of interests of the substantial holder. For further information please download the attached PDF:

Integrated Payment Technologies Ltd announce ISO 27001 Certification (ASX:IP1)

ISO accreditation points to continued focus by InPayTech on strategic initiatives Sydney, Thursday 18 July 2019 Integrated Payment Technologies Limited (InPayTech) (ASX: IP1) announces that it h...read more

Immutep announce Mailing of Offer Booklet for Entitlement Offer (ASX:IMM)

Immutep Limited (ASX Code: IMM) – Mailing of Offer Booklet for Entitlement Offer Immutep Limited (ASX: IMM) (Immutep or the Company) is pleased to announce that it has today mailed a copy of ...read more

Immutep release Cleansing Notice (ASX:IMM)

Notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) To view, please download the attached PDF:

Immutep Announce Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b) (ASX:IMM)

Immutep Limited (ASX:IMM) (the Company), confirms the issue today of 190,476,191 fully paid ordinary shares, pursuant to the placement and appendix 3B announced to ASX on 9 July 2019. The shares raise...read more

Viewing: 1 - 15 of 200 Previous | Next